#CNBC Portal Innovations’ John Flavin: Tariffs on pharma could raise costs and delay drug access

Portal Innovations’ John Flavin: Tariffs on pharma could raise costs and delay drug access
John Flavin, Portal Innovations founder and CEO, joins CNBC’s ‘Squawk on the Street’ to discuss the Trump administration’s proposed pharmaceutical tariffs, the impact on biotech startups and clinical trials, and the outlook for U.S. drug innovation

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”